• Home / GORE® VIABAHN® Endoprosthesis /

Challenge:
Endoluminal Bypass for treating Peripheral Vascular Disease (PVD) in the superficial femoral and iliac arteries


Choice:
GORE® VIABAHN® Endoprosthesis

Interventionalists treating patients suffering from Peripheral Vascular Disease (PVD) in the Superficial Femoral Artery (SFA) require a flexible stent-graft capable of re-lining tortuous arteries.

The GORE® VIABAHN® Endoprosthesis is constructed with a durable, reinforced, biocompatible, expanded polytetrafluoroethylene (ePTFE) liner attached to an external nitinol stent structure. The flexibility of the GORE® VIABAHN® Endoprosthesis enables it to traverse tortuous areas of the SFA and conform closely to the complex anatomy of the artery. W. L. Gore & Associates has now added a heparin-bonded surface to the GORE® VIABAHN® Endoprosthesis.

The GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface is the only device of its kind approved for both the SFA and iliac artery. The stent-graft features the addition of proprietary heparin-bonded technology to the proven combination of ePTFE and nitinol. End-point covalent bonding keeps heparin anchored to the endoprosthesis surface while the bioactive site remains free to interact with the blood.

With a new lower profile, the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface offers more options for endoluminal bypass. This next generation device enables a reduction in delivery profile to 6 Fr for 5 and 6 mm devices and 7 Fr for 7 and 8 mm devices and is delivered over a 0.018" or 0.014" guidewire. For more information, click here (PDF), or contact your local GORE sales associate.

GORE® VIABAHN® Endoprosthesis
in AV Access.

Find out more about
the new 25 cm device.